About this item:

99 Views | 40 Downloads

Author Notes:

Alexander Muir Walker; alec.walker@whiscon.com

AMW led with a first draft, after which WAO and AMW shared equally in preparation of the final text. The editorial is product of WAO and AMW’s participation in a public meeting celebrating the 20th anniversary of the Global Advisory Committee on Vaccine Safety. WAO was the keynote speaker and AMW was the meeting Chair.

Disclosures: None declared.

Subject:

Research Funding:

The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Public, Environmental & Occupational Health
  • vaccines
  • control strategies
  • immunisation
  • public health

Vaccine safety: looking forward and back

Tools:

Journal Title:

BMJ GLOBAL HEALTH

Volume:

Volume 6, Number SUPPL_2

Publisher:

Type of Work:

Article | Final Publisher PDF

Abstract:

Vaccines are among the most cost-effective health interventions. Scientifically rigorous monitoring and evaluation of vaccine safety is critical in order to develop and modify recommendations for vaccine use and in maintaining public trust necessary for the use of vaccines. Even when governments and public health advocates are appropriate in their enthusiasm, vaccines sometimes lack advocates among caregivers or citizens. Outside of pandemics, vaccines do not engender a sense of urgency nor do they offer the satisfaction of seeing a cure. To many patients, the vaccine supporter’s focus on diminished future disease probabilities may seem overly abstract.

Copyright information:

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/rdf).
Export to EndNote